Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Ocumension Therapeutics ( (HK:1477) ).
Ocumension Therapeutics has announced a change in its principal share registrar and transfer office in the Cayman Islands, effective December 31, 2024, to Vistra (Cayman) Limited. This change reflects a strategic move in the company’s operational management, potentially impacting its administrative processes and stakeholder interactions.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry, focusing on the development and commercialization of ophthalmic products.
YTD Price Performance: -3.78%
Average Trading Volume: 1,523,524
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$3.49B
For an in-depth examination of 1477 stock, go to TipRanks’ Stock Analysis page.